Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
July 18, 2019 - 2 minutes
IPO
What’s New on the European Biotech Market?
All over the world, the life sciences industry is booming. Biotechnology, in particular, is experiencing…
May 20, 2019 - 7 minutes
Are Recent IPO Delays Bad News for European Biotech?
Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs…
November 13, 2018 - 4 minutes
Biotech Crosses the Channel to Raise €9.7M for its Diagnostics Tools
Novacyt will use the money raised on the AIM market, London, to expand its manufacturing…
October 18, 2017 - 2 minutes
Ablynx Launches $175M IPO on Wall Street After Phase III Success
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a…
October 4, 2017 - 2 minutes
Scottish Oncology Biotech Aims for €96M IPO in the Nasdaq
Nucana Biomed has filed for a Nasdaq IPO in which it expects to raise up…
September 7, 2017 - 2 minutes
British Biotech Developing New Antibiotics Enters the London Stock Exchange
Destiny Pharma has started trading on the London Stock Exchange to support its search for…
September 4, 2017 - 3 minutes
Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO
After announcing its intentions last month, Zealand Pharma has gone public in the US to…
August 9, 2017 - 2 minutes
Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq
Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is…
July 10, 2017 - 1 minute
Video: Questions about Biotech Capital Markets? Kempen & Co have Answers
In our first Refresh expert track presentation the audience had the chance to learn about…
June 29, 2017 - 2 minutes
UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II
UPDATE (22/05/2017): Argenx has gone above and beyond to secure $115M (€103M) on the NASDAQ. Underwriters…
May 22, 2017 - 3 minutes
Galapagos Shoots Past its IPO in a New Public Round of €315M
After its record €277 IPO on Nasdaq in 2015, Galapagos announced the pricing of its new…
April 19, 2017 - 2 minutes
